Clinical trial

Taurine Supplementation on Cognitive Function in Patients With Diabetes

NCT03410173

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-01-01

PhaseNA

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2018-01-25

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Taurineunresolved

Cognitive Declineunresolved

Diabetes Mellitusunresolved

Interventions

TaurineDRUG · verified · RxNorm: taurine

PlaceboDRUG

Sponsors & collaborators

Third Military Medical Universitylead sponsor

Mapped research locations

ChongqingChongqing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03410173 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.